NT-proBNP用于心力衰竭与心脏应激早期诊断的实用算法:欧洲心脏病学会心力衰竭协会临床共识声明
该共识声明来自欧洲心脏病学会心力衰竭协会,聚焦N末端B型利钠肽原(NT-proBNP)在不同临床场景中的实际应用。NT-proBNP浓度随患者特征和临床场景变化,解读需谨慎以确保诊断适当。文件提供了经验证的切点,用于急诊科排除或确诊急性心力衰竭,以及门诊诊断新发心力衰竭。作者提出「心脏应激」概念,即无症状但具有心衰危险因素(如糖尿病、高血压、冠状动脉疾病)的患者NT-proBNP升高,提示心脏功能不全的发生和风险进一步增加;并提出FIND-HF简易缩写以提醒考虑心衰。
要点
- 急诊科可使用经验证的NT-proBNP切点排除或确诊急性心力衰竭
- 门诊可使用经验证的NT-proBNP切点诊断新发心力衰竭
- 无症状但有糖尿病、高血压或冠状动脉疾病等心衰危险因素者NT-proBNP升高提示「心脏应激」,需警惕心脏功能不全及风险增加
- NT-proBNP浓度随患者特征和临床场景变化,解读需谨慎
- FIND-HF缩写(疲劳、水潴留增加、利钠肽检测、呼吸困难)可作为考虑心衰的提示,助力早期诊断
适用人群与场景
- 急诊科疑似急性心力衰竭的患者,用于排除或确诊急性心衰
- 门诊场景中疑似新发心力衰竭的患者,用于诊断新发心衰
- 无症状但具有心力衰竭危险因素(如糖尿病、高血压、冠状动脉疾病)的患者,NT-proBNP升高提示「心脏应激」
诊断标准与关键阈值
- 经验证的NT-proBNP切点用于急诊科排除或确诊急性心力衰竭
- 经验证的NT-proBNP切点用于门诊诊断新发心力衰竭
- 「心脏应激」概念:无症状且具有心衰危险因素(如糖尿病、高血压、冠状动脉疾病)的患者NT-proBNP水平升高,提示心脏功能不全的发生和风险进一步增加
研究设计与关键结果
- 该文件为欧洲心脏病学会心力衰竭协会的临床共识声明,提出使用NT-proBNP的实用算法以早期诊断心力衰竭和心脏应激
- NT-proBNP浓度随患者特征和临床场景变化,解读需谨慎以确保诊断适当
- 文件提供了经验证的切点,用于急诊科排除或确诊急性心力衰竭,以及门诊诊断新发心力衰竭
- 提出「心脏应激」概念:无症状且具有心衰危险因素(如糖尿病、高血压、冠状动脉疾病)的患者NT-proBNP升高,提示心脏功能不全的发生和风险进一步增加
- 提出FIND-HF缩写(疲劳、水潴留增加、利钠肽检测、呼吸困难),作为考虑心衰的提示,以助力早期诊断心衰
证据类型、等级与局限
- 证据类型:欧洲心脏病学会心力衰竭协会临床共识声明
- 局限:原文未报告局限性
对床旁实践的改变
- 在急诊科,对疑似急性心衰患者使用经验证的NT-proBNP切点可帮助排除或确诊急性心衰
- 在门诊,对疑似新发心衰患者使用经验证的NT-proBNP切点可帮助诊断新发心衰
- 对无症状但具有心衰危险因素(如糖尿病、高血压、冠状动脉疾病)的患者,NT-proBNP升高提示「心脏应激」,应警惕心脏功能不全的发生和风险进一步增加
- 使用FIND-HF缩写(疲劳、水潴留增加、利钠肽检测、呼吸困难)可提醒考虑心衰,从而助力早期诊断
- 解读NT-proBNP浓度时需考虑患者特征和临床场景的差异,谨慎解读以确保诊断适当
指南或共识出处
- 欧洲心脏病学会心力衰竭协会临床共识声明:NT-proBNP用于心力衰竭与心脏应激早期诊断的实用算法(Eur J Heart Fail)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Diagnosing heart failure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure. This document from the Heart Failure Association examines the practical uses of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in various clinical scenarios. The concentrations of NT-proBNP vary according to the patient profile and the clinical scenario, therefore values should be interpreted with caution to ensure appropriate diagnosis. Validated cut-points are provided to rule in or rule out acute heart failure in the emergency department and to diagnose de novo heart failure in the outpatient setting. We also coin the concept of 'heart stress' when NT-proBNP levels are elevated in an asymptomatic patient with risk factors for heart failure (i.e. diabetes, hypertension, coronary artery disease), underlying the development of cardiac dysfunction and further increased risk. We propose a simple acronym for healthcare professionals and patients, FIND-HF, which serves as a prompt to consider heart failure: Fatigue, Increased water accumulation, Natriuretic peptide testing, and Dyspnoea. Use of this acronym would enable the early diagnosis of heart failure. Overall, understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes and reducing healthcare costs.
参考来源
- Bayes-Genis A, Docherty KF, Petrie MC, et al. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. Eur J Heart Fail. 2023. PMID: 37712339. doi:10.1002/ejhf.3036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。